Skip to main content

NeuMoDx 288 and NeuMoDx 96 Molecular Systems

NeuMoDx Molecular has launched the NeuMoDx 288 Molecular System and the NeuMoDx 96 Molecular System in the US. The 288 system loads up to 288 patient samples and has been cleared by the US Food and Drug Administration, while the 96-sample instrument is registered with the FDA for lab-developed testing use. Both instruments are PCR-based and enable continuous, random-access, sample-to-results workflows for on-demand, high-throughput sample processing with an operator walkaway window of up to eight hours. The systems use the firm's proprietary NeuDry reagents which require no refrigeration and have an on-board stability of up to 60 days and room temperature shelf life of more than one year. The instrument can run NeuMoDx's growing menu of infectious disease and sexually transmitted infections assays, as well as LDTs using the company's general-purpose reagents and consumables.
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.